Well‐controlled disease activity with drug treatment will not improve the frailty status of RA patients to robust state: A multicenter observational study (T‐FLAG)

Objectives To investigate a plateau in treatment enhancement for improving the frailty status of rheumatoid arthritis (RA) patients. Methods A total of 345 RA patients who were not robust in 2021 were assigned to the improved (“robust 2022,” n = 51) and non‐improved (“pre‐frailty/frailty 2022,” n = ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of rheumatic diseases 2024-01, Vol.27 (1), p.e14946-n/a
Hauptverfasser: Ohashi, Yoshifumi, Takahashi, Nobunori, Sobue, Yasumori, Suzuki, Mochihito, Sato, Ryo, Maeda, Masataka, Terabe, Kenya, Asai, Shuji, Imagama, Shiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To investigate a plateau in treatment enhancement for improving the frailty status of rheumatoid arthritis (RA) patients. Methods A total of 345 RA patients who were not robust in 2021 were assigned to the improved (“robust 2022,” n = 51) and non‐improved (“pre‐frailty/frailty 2022,” n = 294) groups. Factors associated with “robust 2022” were examined by logistic regression analysis. Patients were assigned to the stable (Follow‐up mean DAS28‐ESR in 2020 and 2021 
ISSN:1756-1841
1756-185X
DOI:10.1111/1756-185X.14946